The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20170829: Trian Partners Strategic Co-Investment Fund-A, L.P.; The Procter & Gamble Company
20170830: Trian Partners Co-Investment Opportunities Fund, LLC; The Procter & Gamble Company
20170831: Trian Partners Strategic Investment Fund-A, L.P.; The Procter & Gamble Company
Payday Support Center, LLC
FTC-Royal Canadian Mounted Police Memorandum of Understanding on Consumer Fraud Enforcement
1703005 Informal Interpretation
Agency Information Collection Activities; Proposed Collection; Comment Request (Fuel Rating Rule)
Block Division, Inc.; Analysis to Aid Public Comment; Proposed Consent Agreement
20170847: Hi-Crush Partners LP; Hi-Crush Proppants LLC
20170725: The Veritas Capital Fund V, L.P.; Harris Corporation
1703004 Informal Interpretation
Prepared Statement of the Federal Trade Commission on Small Business Cybersecurity: Federal Resources and Coordination, Before the Committee on Small Business, United States House of Representatives
Agency Information Collection Activities; Proposed Collection; Comment Request; Extension (Funeral Rule)
20170771: Birch Hill Equity Partners (US) V, LP; Audax Private Equity Fund III, L.P.
20170800: KPKV Holdings, Inc.; OIP Pexco AIV, L.P.
Cooperativa de Médicos Oftalmólogos de Puerto Rico, In the Matter of
OFTACOOP, a Puerto Rico ophthalmologist cooperative, has agreed to settle FTC charges that its actions harmed competition. The complaint charges that OFTACOOP – also known as Cooperativa de Médico Oftalmólogos de Puerto Rico – unlawfully orchestrated an agreement among competing ophthalmologists to refuse to deal with a health plan, MCS Advantage, Inc., and its network administrator, Eye Management of Puerto Rico, LLC. OFTACOOP’s concerted refusal to deal forced MCS to abandon its plan to engage Eye Management to create a lower-cost network of ophthalmologists. MCS was also forced to maintain its then-current reimbursement rates paid to ophthalmologists. According to the complaint, OFTACOOP restrained competition without any justification, in violation of federal antitrust law. The proposed consent order prohibits OFTACOOP from entering into or facilitating agreements between or among ophthalmologists (1) to refuse to deal, or threaten to refuse to deal, with any payor regarding any term, including price terms, or (2) not to deal individually with any payor, or not to deal with any payor other than through OFTACOOP. The order also prohibits information exchanges to facilitate any prohibited conduct, and it bars any attempts to engage in any prohibited conduct. OFTACOOP is also barred from encouraging, suggesting, advising, pressuring, inducing, or trying to induce anyone to engage in any prohibited conduct.